ReviewFrontiers in cardiovascular medicine2023

Advanced progress of the relationship between PCSK9 monoclonal antibodies and hyperglycemic adverse events.

Ruixing Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.